Induction of c-met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 27-33

  Horikawa, Toshiyuki ^a   Sheen, Tzung Shiahn ^b   Takeshita, Hajime ^a   Sato, Hiroshi ^a   Furukawa, Mitsuru ^a   Yoshizaki, Tomokazu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; ETS1 PROTEIN, HUMAN; MATRIX PROTEIN; ONCOPROTEIN; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1;

ANIMAL; ARTICLE; CELL LINE; DOG; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NASOPHARYNX TUMOR; NECK; PATHOLOGY;

ANIMALS; CELL LINE; DOGS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NECK; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS C-MET; TRANSCRIPTION FACTORS; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 0035403317     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61669-0     Document Type: Article

References (42)

1. Cassisi NJ: Tumors of the pharynx. Comprehensive Management of Head and Neck Tumors, vol 1. Edited by SE Thawley, WR Panje, JG Batsakis, RD Lindberg. Philadelphia, W. B. Saunders Co., 1987, pp 614-683
2. Kieff E: Epstein-Barr virus - increasing evidence of a link to carcinoma. N Engl J Med 1995, 333:724-726
3. Liotta LA: Cancer cell invasion and metastasis. Sci Am 1992, 266: 54-63
4. Fidler IJ, Hart IR: Biologic diversity in metastatic neoplasms - origins and implications. Science 1982. 217:998-1001
5. Bhargava MM, Li Y, Joseph A, Jin L, Rosen EM, Goldberg ID: HGF-SF: effects on motility and morphology of normal and tumor cells. EXS 1993, 65:341-349
6. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990, 111:2097-2108
7. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804
8. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W, Comoglio PM: Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor EMBO J 1991, 10:2867-2878
9. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H: The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinoma. Cancer 1999, 85:1894-1902
10. Chen BK, Ohtsuki Y, Furihata M, Takeuchi T, Iwata J, Liang SB, Sonobe H: Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic state. Pathol Res Pract 1999, 195:427-433
11. Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O, Shin T: Expression of c-Met in laryngeal carcinoma. Virchows Arch 1998, 432:331-335
12. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 1995, 147:889-895
13. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994, 54:1630-1633
14. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988, 69:1051-1065
15. Kaye KM, Izumi MK, Mosialos G, Kieff E: The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 1995, 69:675-683
16. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43:831-840
17. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H: Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasiveness. Oncogene 2000, 19:1764-1771
18. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M: Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma Cancer 2000, 89:715-723
19. Yoshizaki T, Sato H, Murono S, Pagano JS, Furukawa M: Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin Exp Metastasis 1999, 17 431-436
20. Takeshita H, Yoshizaki T, Miller WE, Sato H, Furukawa M, Pagano JS, Raab-Traub N: Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol 1999, 73:5548-5555
21. Yoshizaki T, Sato H, Furukawa M, Pagano JS: The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 1998, 95:3621-3626
22. Raab-Traub N, Flynn K, Klein C, Pizza G, De Vinci C, Occhiuzzi L, Farneti G, Caliceti U, Pirodda E: EBV associated malignancies. J Exp Pathol 1987, 3:449-456
23. Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 1995, 31A:658-660
24. Hsu SM, Raine L, Fangen H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1987, 29:577-580
25. Marshall DD, Kornberg LJ: Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma. Laryngoscope 1998, 108:1413-1417
26. Zanetti A, Stoppacciaro A, Marzullo A, Ciabatta M, Fazioli F, Prat M, Comoglio PM, Baroni CD, Ruco LP: Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol 1998, 186:287-291
27. Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Sekine I: Expression of the ets-1 proto-oncogene in human thyroid tumor. Mod Pathol 1999, 12:61-68
28. Murono S, Yoshizaki T, Park CS, Furukawa M: Associations of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Histopathology 1999, 34:432-438
29. Wielenga VJ, van Der Voort R, Taher TE, Smit L, Beuling EA, van Krimpen C, Spaargaren M, Pals ST: Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol 2000, 157:1563-1573
30. Wagatsuma S, Konno R, Sato S, Yajima A: Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 1998, 82:520-530
31. Nakada M, Yamashita J, Okada Y, Sato H: Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors. J Neuropathol Exp Neurol 1999, 58:329-334
32. Kadono Y, Okada Y, Namiki M, Seiki M, Sato H Transformation of epithelial Madin-Darby canine kidney cells with p60 (v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. Cancer Res 1998, 58:2240-2244
33. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H: Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996, 3:393-404
34. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B: Expression of Epstein-Barr virus encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988, 42:329-338
35. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E: Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990, 64:2309-2318
36. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65:1107-1115
37. Miller WE, Earp HS, Raab-Traub N: The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995, 69:4390-4398
38. Huen DS, Henderson SA, Carter DC, Rowe M: The Epstein-Barr virus latent membrane protein 1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995, 10:549-560
39. Eliopoulos AG, Young LS: Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 1998, 16:1731-1742
40. Himelstein BP, Canete SR, Bernhard EJ, Dilks DW, Muschel RJ: Metalloproteinase in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994, 14:246-258
41. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988, 69:1051-1065
42. Pathmanathan RU, Prasad U, Sadler R, Flynn K, Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693-698